This summary was created by AI, based on 1 opinions in the last 12 months.
Treatment.com AI, trading under the symbol TRUE-CN, is making significant strides in the medical sector by leveraging artificial intelligence to enhance efficiency and decision-making processes. The company's proprietary medical language model is trained exclusively on a finite universe of medical data, which aids healthcare professionals, including doctors and receptionists, in diagnosing issues more accurately. The company has established a partnership with the University of Edinburgh, signaling its potential for growth and impact in the medical community. With no debt on its balance sheet and the prospect of becoming cash flow positive shortly through additional deals, Treatment.com AI is carving out a substantial niche in the healthcare AI landscape. Experts note its innovative approach and scalability as key factors that could drive future success.
Treatment.com AI is a Canadian stock, trading under the symbol TRUE-CN on the Canadian Securities Exchange (). It is usually referred to as or TRUE-CN
In the last year, there was no coverage of Treatment.com AI published on Stockchase.
Treatment.com AI was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Treatment.com AI.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Treatment.com AI published on Stockchase.
On 2025-04-01, Treatment.com AI (TRUE-CN) stock closed at a price of $0.48.
Using AI to make things more efficient. Medical language model, using a finite universe of only medical data. Helps doctors to diagnose issues. Can be used by medical office receptionists, doctors, 911 dispatchers, nursing centres. Debt free. Deal signed with University of Edinburgh. A few more deals should make them cashflow positive.